# Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects

> **NCT03977805** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Hetrombopag Olamine

## Key facts

- **NCT ID:** NCT03977805
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-25
- **Primary completion:** 2019-06-13
- **Final completion:** 2019-06-13
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03977805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03977805, "Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03977805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*